Connection

Malik Peiris to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Malik Peiris has written about Antibodies, Viral.
Malik Peiris
Connection Strength
0.704
Antibodies, Viral
  1. Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
    View in: PubMed
    Score: 0.087
  2. Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections. Emerg Microbes Infect. 2019; 8(1):404-412.
    View in: PubMed
    Score: 0.076
  3. West Nile virus infection in horses in Saudi Arabia (in 2013-2015). Zoonoses Public Health. 2019 03; 66(2):248-253.
    View in: PubMed
    Score: 0.075
  4. A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus. Lancet Infect Dis. 2015 May; 15(5):495-7.
    View in: PubMed
    Score: 0.059
  5. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc?R pathway. J Virol. 2011 Oct; 85(20):10582-97.
    View in: PubMed
    Score: 0.045
  6. Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera. J Clin Microbiol. 2021 01 21; 59(2).
    View in: PubMed
    Score: 0.022
  7. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1293-1301.
    View in: PubMed
    Score: 0.021
  8. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.021
  9. Infection of dogs with SARS-CoV-2. Nature. 2020 10; 586(7831):776-778.
    View in: PubMed
    Score: 0.021
  10. The Effect of Influenza Vaccination History on Changes in Hemagglutination Inhibition Titers After Receipt of the 2015-2016 Influenza Vaccine in Older Adults in Hong Kong. J Infect Dis. 2020 01 01; 221(1):33-41.
    View in: PubMed
    Score: 0.020
  11. Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019 04 10; 10(1):1660.
    View in: PubMed
    Score: 0.019
  12. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108.
    View in: PubMed
    Score: 0.019
  13. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia. J Infect Public Health. 2018 May - Jun; 11(3):331-338.
    View in: PubMed
    Score: 0.017
  14. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis. 2017 07; 23(7):1079-1084.
    View in: PubMed
    Score: 0.017
  15. Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015. Emerg Microbes Infect. 2017 Jun 21; 6(6):e56.
    View in: PubMed
    Score: 0.017
  16. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015 Dec; 21(12):2186-9.
    View in: PubMed
    Score: 0.015
  17. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015; 20(41).
    View in: PubMed
    Score: 0.014
  18. Sparse evidence of MERS-CoV infection among animal workers living in Southern Saudi Arabia during 2012. Influenza Other Respir Viruses. 2015 Mar; 9(2):64-7.
    View in: PubMed
    Score: 0.014
  19. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014 Jun; 20(6):1049-53.
    View in: PubMed
    Score: 0.014
  20. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virol J. 2014 May 06; 11:82.
    View in: PubMed
    Score: 0.014
  21. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine. 2007 Jan 08; 25(4):729-40.
    View in: PubMed
    Score: 0.008
  22. First external quality assurance of antibody diagnostic for SARS-new coronavirus. J Clin Virol. 2005 Sep; 34(1):22-5.
    View in: PubMed
    Score: 0.008
  23. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2005 Jul; 43(7):3054-8.
    View in: PubMed
    Score: 0.007
  24. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
    View in: PubMed
    Score: 0.007
  25. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004 Jul; 11(4):665-8.
    View in: PubMed
    Score: 0.007
  26. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2004 May; 42(5):2306-9.
    View in: PubMed
    Score: 0.007
  27. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat Commun. 2021 07 29; 12(1):4678.
    View in: PubMed
    Score: 0.006
  28. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice. Eur J Immunol. 2021 09; 51(9):2296-2305.
    View in: PubMed
    Score: 0.006
  29. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19. Cell Rep. 2021 05 25; 35(8):109173.
    View in: PubMed
    Score: 0.006
  30. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.005
  31. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020 07; 583(7818):834-838.
    View in: PubMed
    Score: 0.005
  32. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Euro Surveill. 2019 Nov; 24(48).
    View in: PubMed
    Score: 0.005
  33. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East. Viruses. 2019 08 05; 11(8).
    View in: PubMed
    Score: 0.005
  34. Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016 06; 22(6):1071-4.
    View in: PubMed
    Score: 0.004
  35. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody. PLoS One. 2014; 9(7):e102415.
    View in: PubMed
    Score: 0.003
  36. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol. 2004 Dec; 42(12):5885-8.
    View in: PubMed
    Score: 0.002
  37. Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome. Clin Diagn Lab Immunol. 2004 Jul; 11(4):699-703.
    View in: PubMed
    Score: 0.002
  38. Virology: SARS virus infection of cats and ferrets. Nature. 2003 Oct 30; 425(6961):915.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.